The aim of the present study was to extract and characterize the EO present in the species, and to evaluate the EO from E. valvata in terms of its inhibition of the AChE enzyme, in order to identify possible species that could represent new sources of cholinesterase inhibitors for the palliative treatment of Alzheimer’s disease. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.